Philadelphia Business Journal |
Research group questions price of GlaxoSmithKline's new asthma drug
Philadelphia Business Journal The Institute for Clinical and Economic Review, a Boston-based nonprofit research organization that studies the effectiveness and value of drugs, issued a draft report Monday that said the price of GlaxoSmithKline's new asthma medicine Nucala should be … Independent group says new Glaxo asthma drug far too expensive |
View full post on asthma – Google News